Suppr超能文献

对自身蛋白质的耐受性涉及其免疫显性决定簇,但不涉及其亚显性决定簇。

Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants.

作者信息

Cibotti R, Kanellopoulos J M, Cabaniols J P, Halle-Panenko O, Kosmatopoulos K, Sercarz E, Kourilsky P

机构信息

U.277 Institut National de la Santé et de la Recherche Médicale, Institut Pasteur, Paris, France.

出版信息

Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):416-20. doi: 10.1073/pnas.89.1.416.

Abstract

We have produced transgenic mice expression hen egg-white lysozyme (HEL) under the control of a ubiquitous promoter, so that in transgenic animals, HEL is presumably present in the serum and thymus throughout the period of establishment of the T-cell repertoire. We show that HEL transgenic H-2d mice with HEL blood levels greater than 10 ng/ml are tolerant to HEL as well as to the immunodominant peptide 108-116. Thus, their T lymphocytes do not proliferate in response to the immunodominant peptide 108-116 after in vivo immunization with HEL or peptide 108-116. In contrast, in transgenic mice tolerant to HEL, the state of tolerance to subdominant peptides 1-18 and 74-96 appears variable and highly depended on HEL blood levels. Complete unresponsiveness is seen when HEL serum levels are high, and this unresponsiveness is reached at a lower HEL concentration for peptide 1-18 than for peptide 74-96. Thus, a hierarchy exists among the three peptides (108-116 much greater than 1-18 greater than 74-96) for induction of a response to HEL and for HEL tolerance induction in T cells specific for these peptides. Persistence in the periphery of autoreactive T cells recognizing subdominant peptides of self-proteins, as shown in this transgenic model, indicates that self-tolerance is limited to a subset of dominant self-peptides and suggests a role for T lymphocytes specific for subdominant determinants in autoimmunity.

摘要

我们制备了在遍在启动子控制下表达鸡蛋清溶菌酶(HEL)的转基因小鼠,使得在转基因动物中,在T细胞库建立期间,HEL可能存在于血清和胸腺中。我们发现,HEL血液水平高于10 ng/ml的HEL转基因H-2d小鼠对HEL以及免疫显性肽108-116具有耐受性。因此,在用HEL或肽108-116进行体内免疫后,它们的T淋巴细胞不会对免疫显性肽108-116发生增殖反应。相比之下,在对HEL耐受的转基因小鼠中,对亚显性肽1-18和74-96的耐受状态似乎是可变的,并且高度依赖于HEL血液水平。当HEL血清水平较高时会出现完全无反应性,并且对于肽1-18,达到这种无反应性的HEL浓度低于肽74-96。因此,在这三种肽(108-116远大于1-18大于74-96)之间,存在诱导对HEL的反应以及在针对这些肽的T细胞中诱导HEL耐受性的等级关系。如该转基因模型所示,识别自身蛋白亚显性肽的自身反应性T细胞在外周的持续存在表明,自身耐受性仅限于一部分显性自身肽,并提示针对亚显性决定簇的T淋巴细胞在自身免疫中发挥作用。

相似文献

引用本文的文献

2
Vaccines for cancer interception in familial adenomatous polyposis.用于家族性腺瘤性息肉病癌症拦截的疫苗。
Front Immunol. 2025 Jan 29;16:1525157. doi: 10.3389/fimmu.2025.1525157. eCollection 2025.
3
Aberrant immunity in the oral cavity-a link with rheumatoid arthritis?口腔中的异常免疫——与类风湿性关节炎有关联?
Front Oral Health. 2024 Jun 14;5:1430886. doi: 10.3389/froh.2024.1430886. eCollection 2024.
7
Metabolism and immunity in breast cancer.乳腺癌的代谢与免疫。
Front Med. 2021 Apr;15(2):178-207. doi: 10.1007/s11684-020-0793-6. Epub 2020 Oct 19.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验